Characterizing the Inflammation Around Dental Implants

NCT05675241 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2023-01-09

No results posted yet for this study

Summary

The use of titanium dental implants has become a common modern treatment to restore teeth. Although the success rate of dental implants is high, inflammation around the dental implant still occurs. The current study will investigate if the inflammation around the implant is due to bacterial infection, hypersensitivity or both.

The goal of this cross-sectional study is to (1) Establish the levels of cytokines in peri-implant crevicular fluid associated with bacterial infection and hypersensitivity reaction; (2) Compare the levels of cytokines associated with hypersensitivity and bacterial infection between healthy implants and inflamed implants (peri-mucositis and peri-implantitis); (3) Determine whether the difference in the levels of cytokines, if they exist, reflects the clinical diagnosis of healthy implants and inflamed implants.

Conditions

  • Peri-Implantitis
  • Peri-implant Mucositis
  • Implant Site Reaction
  • Implant Site Infection
  • Hypersensitivity
  • Implant Site Rash
  • Implant Infection

Interventions

DIAGNOSTIC_TEST

Clinical examination of a dental implant

Clinical examination includes bleeding on probing, pocket depth, gingival biotype, suppuration, gingival index

DIAGNOSTIC_TEST

Radiological Examination

A standardized periapical radiograph in parallax technique will be taken.

DIAGNOSTIC_TEST

Peri-implant crevicular fluid sample collection

A sample of the peri-implant crevicular fluid will be collected using paper strip for 60 seconds. The sample of the fluid will be a resultant of inserting six different strips at the same time in six sites of the implant including mesiobuccal, midbuccal, distobuccal, distopalatal/distolingual, midpalatal/midlingual, mesiopalatal/mesiolingual sites of the implant.

Sponsors & Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    collaborator OTHER
  • McGill University

    lead OTHER

Principal Investigators

  • Heba Allah Madi Dr · McGill University

  • Jocelyne Feine Dr · McGill University

  • Nicholas Makhoul Dr · McGill University & McGill University Health Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-12-01
Completion
2024-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05675241 on ClinicalTrials.gov